“Taken together, the results of this study add to the cumulative evidence in support of plant-based MC (medical cannabis) as a safe and effective treatment option and potential opioid substitute or augmentation therapy for the management of chronic pain symptomatology and quality of life.”
“This feasibility trial demonstrated that a metered-dose cannabis inhaler delivered precise and low THC doses [that] produced a dose-dependent and safe analgesic effect.”
Authors reported that patients administered oral THC experienced a “nine-fold greater reduction in opioid consumption” compared to controls.
Authors reported “an independent negative association between frequent cannabis use and frequent illicit opioid use.” Specifically, subjects who consumed cannabis daily “had about 50 percent lower odds of using illicit opioids every day [as] compared to cannabis non-users.”
Lehigh Valley NORML, and medical cannabis patients from across Pennsylvania, will hold the second in a series of monthly protests at the Department of Health (PaDOH) headquarters on Forster St. “Patients First: Fixing Medical Marijuana in PA” will commence on Wednesday November 13, 2019 from 08:30 AM-5:00 PM.
To honor both those who have bravely served and those who still suffer due to federal cannabis laws, Nevada NORML will be hosting a unique event on Veteran’s Day. The virtual lobby day, a lobbying event done entirely through electronic means, will raise awareness of the many federal pieces of legislation that could benefit veterans.
“Individuals who report having pain limiting that limits their daily activity see large health improvements. This is the strongest evidence that a group with a high probability of pain medication use sees large benefits from medical marijuana laws.”
Adults who purchase retail cannabis typically report using it to mitigate pain and to improve sleep, and often use it in place of conventional medications, according to data published online today in the Journal of Psychoactive Drugs. “Our findings suggest that de facto medical use may be highly prevalent among adult use customers, and that access to an adult use cannabis market may influence individuals’ use of other medications,” authors concluded.